医学
肾功能
肌酐
内科学
肾病
血管紧张素转换酶
血管紧张素转换酶抑制剂
肾脏疾病
背景(考古学)
内分泌学
糖尿病肾病
糖尿病
泌尿科
心脏病学
肾
血压
古生物学
生物
作者
George L. Bakris,Matthew R. Weir
出处
期刊:Archives of internal medicine
[American Medical Association]
日期:2000-03-13
卷期号:160 (5): 685-93
被引量:807
标识
DOI:10.1001/archinte.160.5.685
摘要
A strong association exists between acute increases in serum creatinine of up to 30% that stabilize within the first 2 months of ACEI therapy and long-term preservation of renal function. This relationship holds for persons with creatinine values of greater than 124 pmol/L (>1.4 mg/dL). Thus, withdrawal of an ACEI in such patients should occur only when the rise in creatinine exceeds 30% above baseline within the first 2 months of ACEI initiation, or hyperkalemia develops, ie, serum potassium level of 5.6 mmol/L or greater.
科研通智能强力驱动
Strongly Powered by AbleSci AI